ILS-TAA-ivtRNA-transfected dendritic cell vaccine (Medigene Immunotherapies)

N/A

Report date: 2025/03/20 15:24:50

Base Information

Drug NameILS-TAA-ivtRNA-transfected dendritic cell vaccine (Medigene Immunotherapies)

Drug Alias NameInternal cell localization signals-tumor associated antigens-in vitro transcribed RNA-transfected dendritic cell vaccine

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineCell and gene therapy > Cell therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedigene Immunotherapies GmbH

China Registration ClassN/A

Develop Information

Active CompaniesMedigene Immunotherapies GmbH

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A